E
Elicera Therapeutics AB
STO:ELIC
Elicera Therapeutics AB
STO:ELIC
Price:
2.33
SEK
-0.85%
Market Cap:
kr169.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Elicera Therapeutics AB
STO:ELIC
|
SE |
|
N
|
News Corp
LSE:0K7V
|
US |
|
C
|
Cigna Group
DUS:CGN
|
US |
|
G
|
Gas Plus SpA
SWB:T9O
|
IT |
Wall St Price Targets
ELIC Price Targets Summary
Elicera Therapeutics AB
Elicera Therapeutics AB
Wall Street analysts forecast ELIC stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ELIC is 7.66 SEK with a low forecast of 7.09 SEK and a high forecast of 8.4 SEK.
Lowest Forecast
Price Target
7.09
SEK
204% Upside
Average Forecast
Price Target
7.66
SEK
229% Upside
Highest Forecast
Price Target
8.4
SEK
261% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ELIC's stock price target?
Price Target
7.66
SEK
7.66
SEK
According to Wall Street analysts, the average 1-year price target for ELIC is 7.66 SEK with a low forecast of 7.09 SEK and a high forecast of 8.4 SEK.
What is the Revenue forecast for Elicera Therapeutics AB?
Projected CAGR
96%
96%
Over the last 4 years, the compound annual growth rate for Revenue has been 1 060%. The projected CAGR for the next 3 years is 96%.
